Background and purpose The aim was to evaluate potential predictive factors of smell
recovery in a clinical series of 288 patients presenting olfactory dysfunction (OD) related to …

This study was conducted to determine the prevalence of prolonged neuromuscular
symptoms, including fatigue, anosmia, headache, myalgia, and joint pain in COVID-19 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative pathogen
of coronavirus disease 2019 (COVID-19). It is known as a respiratory virus, but SARS-CoV-2 …

Background. Loss of olfaction is a well-established early feature of Parkinson's disease
(PD). Although olfactory dysfunction has been widely described as a prodromal feature of …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the start of the …

Anosmia is a well-described symptom of Corona Virus Disease 2019 (COVID-19). Several
respiratory viruses are able to cause post-viral olfactory dysfunction, suggesting a …

Since the outbreak of the SARS-CoV-2 pandemic, olfactory disorders have been reported as
a frequent symptom of COVID-19; however, its pathogenesis is still debated. The aim of this …

Background COVID-19 threatens the global community because a large fraction of infected
people are asymptomatic, yet can effectively transmit SARS-CoV-2. Finding and isolating …

Abstract Background Among Coronavirus Disease 2019 (COVID-19) manifestations,
Olfactory (OD) and Gustatory (GD) Dysfunctions (OGD) have drawn considerable attention …

Objectives The aim of this study was to assess the effect of topical steroids on acute‐onset
olfactory dysfunction in patients infected with COVID‐19. Design and Setting Systematic …